PSYLLIUM HUSK

N/A

Manufactured by The Procter & Gamble Manufacturing Company

26,638 FDA adverse event reports analyzed

Last updated: 2026-04-14

About PSYLLIUM HUSK

PSYLLIUM HUSK is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by The Procter & Gamble Manufacturing Company. The most commonly reported adverse reactions for PSYLLIUM HUSK include FATIGUE, DIARRHOEA, CONSTIPATION, OFF LABEL USE, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PSYLLIUM HUSK.

Top Adverse Reactions

FATIGUE1,011 reports
DIARRHOEA967 reports
CONSTIPATION859 reports
OFF LABEL USE779 reports
NAUSEA693 reports
HEADACHE653 reports
DRUG INEFFECTIVE641 reports
PAIN626 reports
DYSPNOEA552 reports
ASTHENIA478 reports
DIZZINESS470 reports
RASH431 reports
FALL429 reports
WEIGHT DECREASED396 reports
VOMITING389 reports
ARTHRALGIA387 reports
COUGH360 reports
PYREXIA351 reports
DEATH348 reports
HYPERTENSION345 reports
PRODUCT USE ISSUE333 reports
BACK PAIN330 reports
MALAISE327 reports
ABDOMINAL PAIN322 reports
INSOMNIA312 reports
DECREASED APPETITE291 reports
PAIN IN EXTREMITY288 reports
JOINT SWELLING282 reports
PNEUMONIA281 reports
HYPERHIDROSIS274 reports
PRURITUS274 reports
URINARY TRACT INFECTION253 reports
HYPERSENSITIVITY249 reports
ABDOMINAL PAIN UPPER240 reports
ABDOMINAL DISTENSION237 reports
WEIGHT INCREASED237 reports
ASTHMA236 reports
ABDOMINAL DISCOMFORT235 reports
PRODUCT DOSE OMISSION ISSUE230 reports
ANXIETY225 reports
CONDITION AGGRAVATED225 reports
DRUG HYPERSENSITIVITY223 reports
INTENTIONAL PRODUCT MISUSE222 reports
EXPOSURE DURING PREGNANCY215 reports
HYPOTENSION215 reports
FEELING ABNORMAL213 reports
GAIT DISTURBANCE211 reports
HEPATIC ENZYME INCREASED210 reports
INFECTION208 reports
UPPER RESPIRATORY TRACT INFECTION208 reports
SOMNOLENCE203 reports
ANAEMIA201 reports
MUSCLE SPASMS200 reports
BLOOD PRESSURE INCREASED198 reports
NASOPHARYNGITIS198 reports
ERYTHEMA196 reports
OVERDOSE193 reports
DEPRESSION191 reports
COVID 19187 reports
THROMBOCYTOPENIA185 reports
INFUSION RELATED REACTION183 reports
RHEUMATOID ARTHRITIS183 reports
RASH ERYTHEMATOUS182 reports
BALANCE DISORDER181 reports
SINUSITIS180 reports
DRUG INTOLERANCE178 reports
IMMUNODEFICIENCY177 reports
PERIPHERAL SWELLING175 reports
FOOD ALLERGY172 reports
DEHYDRATION170 reports
PRESCRIBED OVERDOSE167 reports
FLUID RETENTION165 reports
OEDEMA PERIPHERAL165 reports
FLATULENCE161 reports
DYSPEPSIA156 reports
CHEST PAIN155 reports
DRY MOUTH151 reports
INCORRECT DOSE ADMINISTERED151 reports
GASTROOESOPHAGEAL REFLUX DISEASE149 reports
TREMOR143 reports
PRODUCT USE IN UNAPPROVED INDICATION141 reports
CONTUSION139 reports
HYPOAESTHESIA137 reports
HAEMOGLOBIN DECREASED136 reports
HOT FLUSH135 reports
OSTEOARTHRITIS135 reports
MYALGIA133 reports
PSORIASIS132 reports
CONFUSIONAL STATE130 reports
ALOPECIA127 reports
VISION BLURRED127 reports
ATRIAL FIBRILLATION125 reports
CHEST DISCOMFORT125 reports
INJECTION SITE PAIN124 reports
MEMORY IMPAIRMENT124 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION123 reports
NEUROPATHY PERIPHERAL122 reports
MUSCULAR WEAKNESS121 reports
GASTROINTESTINAL DISORDER119 reports
MOBILITY DECREASED116 reports

Report Outcomes

Out of 9,359 classified reports for PSYLLIUM HUSK:

Serious 60.9%Non-Serious 39.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female5,043 (57.8%)
Male3,667 (42.0%)
Unknown14 (0.2%)

Reports by Age

Age 77210 reports
Age 71208 reports
Age 78195 reports
Age 80184 reports
Age 76181 reports
Age 73176 reports
Age 74174 reports
Age 72169 reports
Age 67162 reports
Age 58157 reports
Age 64153 reports
Age 79153 reports
Age 65152 reports
Age 69151 reports
Age 60150 reports
Age 66150 reports
Age 70145 reports
Age 75145 reports
Age 68141 reports
Age 82140 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PSYLLIUM HUSK?

This profile reflects 26,638 FDA FAERS reports that mention PSYLLIUM HUSK. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PSYLLIUM HUSK?

Frequently reported terms in FAERS include FATIGUE, DIARRHOEA, CONSTIPATION, OFF LABEL USE, NAUSEA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PSYLLIUM HUSK?

Labeling and FAERS entries often list The Procter & Gamble Manufacturing Company in connection with PSYLLIUM HUSK. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.